REBIF
Google image searchProduct monograph
Active ingredient
interferon beta-1a, 22 MCG/0.5 ML
DIN: 02237319
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: PRE-FILLED SYRINGE
Schedule: Prescription / Schedule D
Company: EMD SERONO, A DIVISION OF EMD INC., CANADA
Date: 23-FEB-1998
ATC:
- L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
- L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
- L03AB — Interferons (ATC, ATC/DDD)
- L03AB07 — INTERFERON BETA-1A (ATC/DDD)
Reference brand drug: Avonex, Rebif
Pharmaceutical standard: MFR
